You’ve likely heard a lot lately about a link between the popular heartburn medication Zantac and cancer. Or, maybe you’ve noticed Zantac missing from the pharmacy shelves, along with its generic counterpart ranitidine. All over the country, pharmacies like Walmart, CVS and Walgreens have pulled all Zantac and ranitidine products from their stores, as well as a voluntary recall of Zantac from pharmaceutical company Sanofi.

What is Zantac (ranitidine)?

Zantac is part of a class of medications called H2 blockers. These types of medications treat gastrointestinal conditions like acid indigestion, heartburn and gastroesophageal reflux disease (GERD), by decreasing the amount of acid in the stomach. Even with generic versions available, Zantac is one of the most popular brands of ranitidine in the United States.

How is Zantac linked to cancer?

Here’s the backstory. Back in September 2019, a pharmaceutical testing company named Valisure notified and petitioned the FDA about discovering unacceptable levels of NDMA in samples of Zantac. N-nitrosodimethylamine, or NDMA, is classified by the World Health Organization as a probable human carcinogen. After Valisure’s petition, the FDA notified the public about the link between NDMA and Zantac and announced they’d be opening their own investigation. Soon after, Sandoz issued a recall for their ranitidine capsules, followed by Sanofi’s Zantac recall.

What are the side effects and risks of NDMA?

NDMA is a compound found in both industrial and natural processes. It’s also found in various levels in our soil, water and even some food products. In low levels, NDMA presents very little risk to human health. However, when exposed to or ingested in high levels, or over a long period, NDMA can cause cancer and other serious health conditions.

According to medical experts on ABC News, overexposure to NDMA can cause abdominal cramps, dizziness, fever, jaundice, nausea and vomiting. Long-term exposure to NDMA can cause reduced function of the kidneys and lungs, as well as an increased risk of liver, kidney and lung cancers.

Do I have a case if I use or used Zantac?

First, if you are currently using Zantac or another ranitidine product, consult with your doctor immediately about stopping and switching to an alternate medication.

To qualify for a Zantac cancer action, you first must prove use. This shouldn’t be difficult if you were taking prescription ranitidine, as your pharmaceutical and medical records are easily accessible. If you were using an over-the-counter (OTC) version of the medication, you may need to prove it by showing receipts, doctor’s notes or other corroborating evidence. Our attorneys can help you with this.

Next, you must show an injury, like the ones we’ve talked about earlier. You’ll need to supply your medical records and history to document your condition. Finally, you’ll have to show that your Zantac use contributed to your cancer and injuries. Experienced defective drug lawyers can work with you to build a strong case.

Is this an ongoing situation?

Yes. The FDA continues to monitor ranitidine, Zantac, NDMA and all other information regarding contamination and impurities, keeping the public informed via press releases and updates. If you or a family member are a regular user of Zantac and have suffered illness or injury, it’s imperative you seek legal representation immediately, as this litigation is constantly evolving.

The Alabama injury attorneys at Mezrano Law Firm are never afraid to take on the big pharma companies when they put profits over people. If you or a loved one developed cancer after taking Zantac or ranitidine, we’ll fight to secure you the compensation you deserve. We serve the citizens of Birmingham, Mobile, Florence, Tuscaloosa, Gadsden, and Montgomery for your convenience. To schedule a free case evaluation, reach out to us through our contact page or call 205-206-6300 today.